To increase (tumor) vaccine effi cacy, there is an urgent need for phenotypic and functional characterization of human Dendritic Cell (DC) subsets residing in lymphoid tissues. In this study we identifi ed and functionally tested four human conventional DC (cDC) subsets within skin-draining sentinel lymph nodes (SLN) from early-stage melanoma patients. These SLN were all tumor negative and were removed on average 44 days after excision of the primary melanoma. As such, they were considered representative of steady state conditions. Upon comparison with skin-migrated cDC, two CD1a + subsets were identifi ed as most likely skin- respectively. Whereas the CD1a + skin-derived subsets displayed higher levels of phenotypic maturation, they were associated with lower levels of infl ammatory cytokine release, and inferior in terms of allogeneic T cell priming and IFNγ induction. Thus, despite their higher maturation state, skin-derived cDC (and LC in particular) proved inferior T cell activators as compared to the CD1a -cDC subsets residing in melanoma-draining LN. These observations should be considered in the design of DC-targeting immunotherapies.
Abstract
To increase (tumor) vaccine effi cacy, there is an urgent need for phenotypic and functional characterization of human Dendritic Cell (DC) subsets residing in lymphoid tissues. In this study we identifi ed and functionally tested four human conventional DC (cDC) subsets within skin-draining sentinel lymph nodes (SLN) from early-stage melanoma patients. These SLN were all tumor negative and were removed on average 44 days after excision of the primary melanoma. As such, they were considered representative of steady state conditions. Upon comparison with skin-migrated cDC, two CD1a + subsets were identifi ed as most likely skin- 4 . Many questions remain as to which DC type to use, how to stimulate them, or where best to administer the DC in order to achieve vaccination with mature, migratory, and Th1-inducing DC that provoke an effi cient anti-tumor immune response [5] [6] [7] .
An ever increasing insight in specialized functions of murine DC subsets is sadly mirrored by a lack of knowledge on how human DC relate to mouse DC and whether subsets that have been identifi ed in mice have a (phenotypically different, but functionally equivalent) counterpart in humans 4;8-11 . In particular the inter-relationship between non-plasmacytoid, conventional DC (cDC) subsets has been obscure, in large part due to their plasticity and dynamic changes in their differentiation and maturation state, which is accompanied by shifts in associated phenotypic markers 12 . In mice, extensive DC subset analyses have been performed through the use of transgenic models, the ability to track and monitor cells in vivo and to remove specifi c organs, whereas in humans, especially for DC subsets present at low frequencies in lymphoid tissues such as lymph nodes (LN) (0.1-2 %), this is more complicated [13] [14] [15] . As skin is generally regarded an attractive site for delivery of vaccines, identifi cation and characterization of DC subsets in skin-draining LN is particularly relevant. Although previous immunohistochemical studies have indicated the presence of both LC and DDC in steady-state skin-draining LN 14, 15 , until now it has proven technically unfeasible to perform more extensive fl owcytometry-based phenotypic and functional cDC subset analyses.
We and others previously described a method to obtain viable cells from melanoma-draining Sentinel Lymph Nodes (SLN) without hindering routine diagnostic procedures 16, 17 . We have employed this methodology to study the in vivo effects of immune modulators such as the CpG-B TLR9-ligand PF-3512676 and Granulocyte/Macrophage-Colony Stimulating Factor (GM-CSF) on DC and T cell subsets in the SLN [18] [19] [20] [21] . In the context of three separate clinical
Phase II trials, we have collected a sizeable number of SLN from untreated or saline placeboadministered melanoma patients, from which phenotypic DC data were obtained through multi-parameter fl owcytometric analysis and of which viable cells were cryopreserved for further functional analysis. From these, we have selected tumor-negative SLN from Stage I-II melanoma patients, which were removed 1-2 months after excision of the primary melanoma, to perform an in-depth analysis of cDC subsets in steady state skin-draining LN. In four discernable cDC subsets we have studied the differential expression patterns of markers which have been linked to maturation, co-stimulation, and cross-presentation or tolerance-induction (i.e. BDCA3/CD141, CD103, B7-H1/-H4), or that identify human skin-derived subsets (i.e.
CD1a, DC-SIGN, E-cadherin, and Langerin), and we performed comparative analyses with human skin-emigrated cDC.
Our data indicate the presence of at least two skin-derived and two LN-resident cDC subsets with differential maturation states and functional T cell priming abilities. In analogy to recent mouse data 14;22-25 , Langerin + cells, with lower Langerin expression levels than found in LC,
were observed within the DDC subset derived from human skin and its putative equivalent from skin-draining LN, as well as BDCA3/CD141 + and CD103 + cDC. These data represent the fi rst functional characterization of human LN cDC subsets and supply new leads for the development of human DC-targeted immunotherapies. Functiomal comparison of human LN cDC subsets Netherlands) 26 . Cells were allowed to migrate from the biopsies for 48 hours, after which they were harvested and analyzed by fl ow cytometry.
Materials and Methods

Patient selection and isolation of viable lymph node cells
Flowcytometric phenotyping
Human SLN single-cell suspensions were phenotypically analyzed by fl ow cytometry using Flow-based cell sorting cDC subsets were isolated by fl uorescent cell sorting using a FACS Aria (BD) and BD Diva software. Cells (10-30x10 6 ) were fi rst stained with 5 μl CD1a-PE, 10 μl CD14-PerCP_Cy5 and 10 μl CD11c-APC in sterile PBS for 30 minutes at 4 o C. After staining the cells were washed and taken up in IMDM, supplemented with 10 % fetal calf serum (FCS) (HyClone), 100 IU/ml sodium penicillin (Yamanouchi Pharma, Leiderdorp, The Netherlands), 100 μg/ ml streptomycin (Radiumfarma-Fisopharma, Naples, Italy), 2.0 mM L-glutamine (Invitrogen, Breda, The Netherlands) and were fi ltered over a cell fi lter (Miltenyi) to remove clumps that could clog the system. The four cDC subsets were sorted over 4 streams at a time, based on the expression of the three surface markers. After sorting, cells were washed and were used for functional assays.
Mixed Leukocyte Reaction
Peripheral blood leukocyte (PBL) proliferation induced by sorted LN cDC subsets was assessed by Mixed leukocyte Reaction (MLR) with a carboxyfl uorescein succinimidyl ester (CFSE)-based proliferation read-out 27 . Allogeneic donor PBL were labeled with 1 μM CFSE in PBS supplemented with 5 % FCS for 7 minutes at 37 o C (in a water bath). Cells were washed three times with PBS/5 % FCS and once with IMDM + 10 % HPS, penicillin, streptomycin and glutamine. PBL (10,000 -30,000) (1x10 6 cells/ml) were stimulated with 1000-3000 LN-cDC (0.1x10 6 cells/ml) (10:1 ratio responder:stimulator cells). PBL proliferation, measured by CFSEdilution, was analyzed by fl ow cytometry on day 7. Prior to harvesting, culture supernatants were collected for T cell cytokine analysis (see paragraph on cytokine analysis below).
Imprint specimens and cytospins
Imprints were made from the SLN cutting surface that was not scraped and immunocytochemically analyzed. The imprints and cytospins were air-dried overnight, fi xed in acetone for 10 minutes, and stained using a biotin-streptavidin staining technique as described previously 28 Images were captured using a Leica DC200 digital camera (Leica Microsystems, Rijswijk, The Netherlands) and Leica DC Viewer (Leica Microsystems, Heerbrugg, Germany).
Cytokine analysis
Freshly isolated SLN cells were cultured overnight at 37 °C (1x10 5 anti-mouse immunoglobulin (1:100 in PBS; DAKO, Glostrup, Denmark), in complete medium with 10 % FCS at a concentration of 10 6 /mL/well for 1 hour at 4 ºC. Subsequently, the plates were transferred to a humidifi ed incubator and cultured overnight at 37 ºC, after which the culture supernatants were harvested and stored at -20 °C until analysis. Supernatants were analyzed using the infl ammatory cytokine bead array (CBA) kit or the Th1/Th2 CBA kit (both from BD Biosciences, USA) for the simultaneous fl ow cytometric detection of IL-8, IL-1β, IL-6, IL-10, TNFα, and IL-12p70, or IL-2, IL-4, IL-5, IL-10, TNFα, and IFNγ, respectively, following the manufacturer's instructions and using CBA analysis software (BD Biosciences).
Statistical Analyses
Differences between DC subsets were analyzed using the one-way Anova test. and CD14 expression in these populations was mutually exclusive. Figure 1B shows the frequencies of the four cDC subsets as percentages of total leukocytes within the SLN single cell suspensions (n=14) and indicates the CD14 + subset to be relatively rare under steady state conditions. The CD1a + subsets had higher forward (FSC) and side scatter (SSC) properties ( Figure 1C ), suggestive of a larger and more DC-like morphology. This was confi rmed by cytochemical analysis of the FACS-sorted subsets ( Figure 1D ) as well as by imprint cytology of the SLN, which also revealed a paracortical localization of the CD1a + cDC ( Figure 1E ).
Like CD1a, Langerin has been associated with skin-derived cDC subsets and we found it expressed on large cells scattered throughout the paracortical T cell areas ( Figure 1E ). The CD14 + subset had a smaller, monocyte-like appearance ( Figure 1D ) and was often localized around vessel-like structures (see right panel Figure 1E ). Nevertheless, CD14 + protrusions that extended between lymphocytes, suggestive of a DC-like appearance, were clearly discernable in situ (marked by arrows in Figure 1E ). Figure 3A ) and co-inhibitory ( Figure 3B ) receptors at their cell surface.
Flowcytometric identifi cation of Langerin
Expression of co-stimulatory and co-inhibitory receptors on human LN-cDC
Both CD1a -cDC subsets displayed a relatively immature phenotype as refl ected by low percentages and low expression levels of the various activation markers and co-stimulatory molecules, like CD40, CD83, CD80 and CD86. In contrast, the CD1a + skin-derived cDC subsets expressed signifi cantly higher intensity levels of all the tested co-stimulatory molecules, with the CD1a + CD11c hi DDC-like subset displaying the most mature phenotype, clearly demonstrated by its superior expression levels of CD40, CD80, and CD83 ( Figure 3A ). In accordance with their mature state, most CD1a + cDC in addition expressed the co-inhibitory molecules B7H1
and B7H4. In contrast, generally less than half of the CD1a -CD11c + cDC expressed these surface markers and at lower intensity levels as compared to the CD1a + LN-DC ( Figure 3B ). 
Identifi cation of BDCA3/CD141 and CD103 expressing cDC subsets
Recently, human BDCA3/CD141 + cDC in peripheral blood were identifi ed as cross-presenting DC that most closely resembled the much-studied splenic murine CD8α + cDC subset, established as mainly responsible for in vivo cross-presentation [9] [10] [11] . Similarly, CD103 is also expressed on cDC subsets that were associated with cross-presentation 32, 33 . In the SLN, both CD1a -cDC subsets were found to express BDCA3 ( Figure 4A ). While high percentages of BDCA3-expressing cells were detected both in the CD14 -and CD14 + subsets, expression levels were much higher on the CD11c + CD14 -subset ( Figure 4A and C) . A small percentage of the CD1a + CD11c int LC subset also expressed low levels of BDCA3 ( Figure 4A and C) . In mice, CD103 expression has been associated with a small subset of Langerin + DDC that patrols the dermis in the steady state and can migrate to skin-draining LN 22 . In contrast, in human skin-draining SLN CD103 was almost exclusively expressed on the CD11c + subset (see Figure 1E ), we utilized the high BDCA3 levels that characterize the CD1a -CD14 -cDC subset to study its localization and morphology in LN. Immunocytochemical analysis of SLN imprints showed these cells to be located in the paracortical T cell areas of the LN and to display a classical DC morphology ( Figure 4D ). Indeed, high magnifi cation microscopy revealed long BDCA3 + protrusions interdigitating between the lymphocytes ( Figure   4D , righthand panel).
T cell stimulatory capacity of LN cDC subsets
To study their T cell stimulatory capacity, isolated SLN cDC subsets from three donors were cocultured with CFSE-labeled allogeneic PBL in independent experiments. Surprisingly, in view of its relatively immature phenotype (Figure 2A ), the CD1a -CD11c + CD14 -cDC subset turned out to be the most powerful inducer of T cell proliferation ( Figure 5A,B) . On the other hand, in seeming contrast with their mature phenotype, the CD1a + cDC subsets, and the CD1a hi CD11c int LC in particular, were poor inducers of T cell alloreactivity ( Figure 5A,B) . Of the T cell cytokines measured in supernatants of the MLR cultures, only IFNγ was consistently detected. As shown in Figure 5B , high levels of IFNγ were induced in particular by the CD1a -CD11c + CD14 + subset, while the CD1a hi CD11c int LC proved poor stimulators in this respect.
To further assess the association of the four cDC subsets with a microenvironment conducive to T cell activation, available data were analyzed to determine their relative frequencies in SLN single-cell suspensions in relation to spontaneous ex vivo release levels of infl ammatory cytokines as well as to anti-CD3/anti-CD28 induced release of T cell cytokines. Consistently negative correlations with the release of infl ammatory cytokines (IL-6, IL-1β, and IL-12p70s)
were observed for both of the CD1a + skin-derived subsets, whereas positive correlations (at varying levels of signifi cance) were found for the CD1a -CD11c + LN-resident subsets ( Figure   5C ). Accordingly, T cell cytokine release levels correlated with CD1a -subset content rather than with CD1a + subset frequencies, although not signifi cantly so due to the low numbers of available data (shown for IFNγ, IL-2 and IL-4 in Figure 5D ).
Functiomal comparison of human LN cDC subsets
Discussion
The lack of knowledge on phenotype and function of human cDC subsets in skin-draining lymph nodes has proven a major hurdle in translating pre-clinical DC-based therapies in mice into successful DC-based therapies for humans 4, 8 . The data provided in this manuscript are a fi rst step towards a more detailed discrimination of different human LN-cDC subsets, both in terms of phenotype and of function. This information could provide new insights leading to improved immunotherapeutic strategies. In particular the identifi cation of LN-cDC subsets which are primarily tolerogenic and thereby disadvantageous for anti-tumor immunity, and the exploration of ways in which to break this tolerance, are of prime importance in this regard.
On the other hand, establishing which DC subsets are the most potent in inducing anti-tumor immunity and studying ways to promote their functions may push the envelope for future immune-enhancing therapies.
The skin is commonly regarded as an attractive gateway for the delivery of (tumor) vaccines.
A dense network of DC and lymphatic vessels facilitates antigen capture and subsequent transport to the draining LN. In mice, different cDC subsets in skin have been described in detail, delineating their origins and specialized functions. LC in the steady state are derived from precursor cells residing in the skin, whereas under infl ammatory conditions they can also develop from monocytes originating from the blood 14, 34 . There is evidence to suggest that upon their activation and migration to LN, LC preferentially bind and activate T cells 35 .
Recently, Langerin + and CD103 + DDC were identifi ed in murine studies as a major migratory DDC subset with the ability to cross-present proteins from the skin environment 22, 33, 36 . It has been suggested that CD1a + DDC may be the human equivalent of this subset 35 , but evidence to back up this claim has so far been lacking. Beside these skin-migrated cDC subsets, murine skin-draining lymph nodes also harbor resident subsets, most notably the CD8α + subset with a superior CD8 + T cell activating capacity and the ability to cross-present antigens 13, 14 .
Clearly, to optimize the effi cacy of cutaneously applied vaccines in humans, it is of the utmost importance to positively identify functional equivalents of these DC subsets in human skin and LN. To establish a baseline, it is vital to study these subsets in steady state tissues, which, in the case of skin-draining LN, is near-impossible. We therefore used SLN that drained earlystage melanomas. We feel that single-cell suspensions from tumor negative SLN of which the primary tumor has been removed over a month before, provide a valid model resembling the steady state. Nevertheless, interpretation of the obtained results warrants caution as some lingering tumor infl uences cannot be excluded.
Based on 4-color fl ow cytometry and by making head-to-head comparisons with skin-emigrated DC, we discerned and characterized four human cDC subsets in skin-draining LN, i.e. the skin- 28 . Thus, in contrast to the CD1a + subsets, the CD1a -subsets did not appear to have analogues among the skin-emigrated DC. Rather than deriving from skin, we propose these CD1a -LN-resident subsets to originate from precursors in the blood. It could be envisioned that they might be mobilized and rapidly activated under infl ammatory conditions. This would be in line with their superior allogeneic T cell priming and cytokine release properties and the observed correlation between their frequencies and ex vivo pro-infl ammatory, T cell activating cytokine profi les ( Figure 5 ).
DC-mediated cross-presentation of tumor-derived antigens to CD8 + T cells is vital for the elicitation of an effective anti-tumor immune response. In murine spleens CD8α-expressing DC have been pinpointed as mainly responsible for cross-presenting exogenous antigens on MHC class I and for effective CTL priming 36, 37, 44, 45 . Interestingly, a genome-wide transcriptional profi ling study suggested BDCA3 + DC in LN to be the human equivalent of this CD8α + DC subset 46 . Recently, three groups independently confi rmed this observation and reported BDCA3 + cDC in human blood to most closely resemble the murine CD8α + subset, both in phenotype and in cross-presenting ability [9] [10] [11] . In reaction to this, others have compared mammalian DC subsets with cross-priming abilities for their relatedness and found that mouse CD8α 33 . Additional polychromatic fl owcytometric and functional analyses will have to reveal the exact (co-)expression profi les of BDCA3, CD103, CLEC9A, XCR1, SIRP, CADM1, and/or CD205 and how these profi les may defi ne specifi c LN-cDC subsets with demonstrable cross-presenting ability. Cross-presentation may result in either T cell activation or tolerization, depending on input from the microenvironment and may independently differ per defi ned cDC subset 32, 50 . In this regard, extensive C-type
Lectin and Toll-like Receptor expression profi ling of the discerned cDC subsets is of the utmost importance.
In summary, whereas the CD1a + LC-and DDC-like subsets, derived from human skin-draining LN, displayed higher phenotypic maturation, the LN-resident BDCA3/CD141 + subsets were more potent in terms of allogeneic T cell priming and cytokine release. The SLN-derived LC subset in particular proved a poor inducer of allogeneic T cell proliferation and cytokine release. These data refl ect earlier fi ndings from in vivo murine studies and reveal phenotypic and functional heterogeneity among cDC subsets in skin-draining LN, which should be taken into account in the design of cutaneously applied (tumor) vaccines.
